Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

Clinical research institutions, universities and academic medical centers, pharmaceutical companies, medical device manufacturers, and other health and life sciences industry organizations are focused on protecting and leveraging their investments in research, development and innovation. We provide critical counseling to help preserve your assets, mitigate regulatory risk and get your products to market as expediently as possible. From clinical trials and product design to premarket approval and product launch, our team of attorneys and other professionals guides you in carefully crafting clinical trial, licensing, research and development, and other agreements; obtaining appropriate patents or other intellectual property protection; obtaining FDA and other regulatory approvals; addressing reimbursement strategies; and preparing for product liability defenses. We help you take advantage of federal tax exemptions, strategically change clinical trial processes or product designs, and conduct evidence-based advocacy to enhance federal support for areas of distinction. We are recognized for our work with clients in the areas of orphan drugs, patient-focused drug development, pediatrics and Alzheimer’s disease, among many others, and work with you to develop and win approval of treatments and medications that address some of today’s most pressing, unmet needs. We have the experience to help bring innovation to the industry and, most importantly, to patients.

Insights & Events

Latest

Updates August 2025

‘America’s AI Action Plan’ and More Developments for the Tech, Financial Services, Insurance and Health Care Sectors

Artificial Intelligence Briefing
8 min read  
Updates August 2025

Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More

Biopharma & Medical Devices Briefing
7 min read  
Speaking Engagement Recap August 01, 2025

Advanced Governance: Credentialing with Confidence: What Every Board Member Should Know

Minnesota Hospital Association Trustee Conference
1 min read  
Speaking Engagement Recap August 01, 2025

Governance: Board Oversight and Compliance: Navigating Governance in a Complex Health Care Environment

Minnesota Hospital Association Trustee Conference
1 min read  
Updates July 2025

FDA Joins the Data Security Program Conversation: The Agency’s Scrutiny of Cross-Border Clinical Trials & 28 C.F.R. Part 202 Exemptions

FDA Contends Some Clinical Trials May Have Exposed Americans’ Sensitive Genetic Data to Misuse by Foreign Governments
6 min read  
Updates July 2025

The UK’s Data (Use and Access) Act 2025

Important Changes to UK Data Laws Including the UK General Data Protection Regulation
7 min read  
Updates June 2025

Texas Genomic Act: A New Era of Genetic Privacy Legislation

Including Prohibitions on Genetic Sequencing, Storage and Sale of Genomic Information
7 min read  
Press Release May 2025

Faegre Drinker Grows Life Sciences Consulting Team With Nationally Recognized Patient Experience Researcher Holly Peay, PhD

2 min read  
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read  
Press Release May 2025

Faegre Drinker Welcomes Former Senate HELP Committee General Counsel Barrett Tenbarge to Government and Regulatory Group

3 min read  
Insights
Updates August 2025

‘America’s AI Action Plan’ and More Developments for the Tech, Financial Services, Insurance and Health Care Sectors

Artificial Intelligence Briefing
8 min read  
Updates August 2025

Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More

Biopharma & Medical Devices Briefing
7 min read  
Updates July 2025

FDA Joins the Data Security Program Conversation: The Agency’s Scrutiny of Cross-Border Clinical Trials & 28 C.F.R. Part 202 Exemptions

FDA Contends Some Clinical Trials May Have Exposed Americans’ Sensitive Genetic Data to Misuse by Foreign Governments
6 min read  
Updates July 2025

The UK’s Data (Use and Access) Act 2025

Important Changes to UK Data Laws Including the UK General Data Protection Regulation
7 min read  
Updates June 2025

Texas Genomic Act: A New Era of Genetic Privacy Legislation

Including Prohibitions on Genetic Sequencing, Storage and Sale of Genomic Information
7 min read  
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read  
Published Articles May 2025

The Booming Business of Botox: Legal Considerations for Medical Spas

2 min read  
Updates May 2025

FDA Identifies Data Quality and Study Conduct Concerns With Raptim Research and Requires Sponsors to Submit Replacement Study Data

Reminder of Importance of Adequately Vetting Contract Research Organizations
5 min read  
May 2025

The Hidden Dangers of Alternative Funding Programs

1 min read  
Updates February 2025

A Deeper Dive Into the Making America Healthy Again Commission’s Executive Order and Its Implications

While Some Elements Lie Within the Mainstream, Others Are Cause for Concern
5 min read  

Related Legal Services